1. Home
  2. ENPH vs GRFS Comparison

ENPH vs GRFS Comparison

Compare ENPH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enphase Energy Inc.

ENPH

Enphase Energy Inc.

HOLD

Current Price

$43.25

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.29

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENPH
GRFS
Founded
2006
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.2B
IPO Year
2012
2006

Fundamental Metrics

Financial Performance
Metric
ENPH
GRFS
Price
$43.25
$9.29
Analyst Decision
Hold
Hold
Analyst Count
24
2
Target Price
$42.89
$10.15
AVG Volume (30 Days)
9.7M
449.6K
Earning Date
02-03-2026
07-28-2022
Dividend Yield
N/A
1.53%
EPS Growth
71.77
N/A
EPS
1.29
0.64
Revenue
$1,472,985,000.00
$8,821,017,248.00
Revenue This Year
N/A
$5.36
Revenue Next Year
$10.36
$5.15
P/E Ratio
$34.22
$17.85
Revenue Growth
10.72
7.31
52 Week Low
$25.78
$6.19
52 Week High
$70.78
$11.14

Technical Indicators

Market Signals
Indicator
ENPH
GRFS
Relative Strength Index (RSI) 54.75 52.06
Support Level $47.07 $9.07
Resistance Level $52.24 $9.64
Average True Range (ATR) 3.29 0.21
MACD 0.09 -0.01
Stochastic Oscillator 47.88 42.47

Price Performance

Historical Comparison
ENPH
GRFS

About ENPH Enphase Energy Inc.

Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: